LIN; CLARA JEOU JEN
Patent Applications and Registrations
Patent applications and USPTO patent grants for LIN; CLARA JEOU JEN.The latest application filed is for "diaminopyrimidines as p2x3 and p2x2/3 antagonists".
- LIN; CLARA JEOU JEN - PALO ALTO CA
| Patent | Date |
|---|---|
| Diaminopyrimidines As P2x3 And P2x2/3 Antagonists App 20210009531 - BROKA; CHRIS ALLEN ; et al. | 2021-01-14 |
| Diaminopyrimidines As P2x3 And P2x2/3 Antagonists App 20200115347 - Broka; Chris Allen ; et al. | 2020-04-16 |
| Diaminopyrimidines As P2x3 And P2x2/3 Antagonists App 20190270713 - BROKA; CHRIS ALLEN ; et al. | 2019-09-05 |
| Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators Grant 10,023,589 - Arora , et al. July 17, 2 | 2018-07-17 |
| Diaminopyrimidines as P2X.sub.3 and P2X.sub.2/3 antagonists Grant 9,556,127 - Broka , et al. January 31, 2 | 2017-01-31 |
| Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators Grant 9,255,110 - Arora , et al. February 9, 2 | 2016-02-09 |
| Diaminopyrimidines As P2x3 And P2x2/3 Antagonists App 20140357629 - Broka; Chris Allen ; et al. | 2014-12-04 |
| PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS App 20140303149 - Arora; Nidhi ; et al. | 2014-10-09 |
| Diaminopyrimidines as P2X.sub.3 and P2X.sub.2/3 antagonists Grant 8,846,705 - Broka , et al. September 30, 2 | 2014-09-30 |
| Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof Grant 8,513,425 - Iyer , et al. August 20, 2 | 2013-08-20 |
| Heteroaryl Pyrrolidinyl And Piperidinyl Ketone Derivatives And Uses Thereof App 20120065225 - Iyer; Pravin ; et al. | 2012-03-15 |
| PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS App 20120015962 - Arora; Nidhi ; et al. | 2012-01-19 |
| Pyrrolidinyl and piperidinyl ketone derivatives and uses thereof Grant 8,084,623 - Iyer , et al. December 27, 2 | 2011-12-27 |
| Heterocyclic antiviral compounds Grant 8,071,797 - Labadie , et al. December 6, 2 | 2011-12-06 |
| Diaminopyrimidines As P2x3 And P2x2/3 Antagonists App 20110077242 - Broka; Chris Allen ; et al. | 2011-03-31 |
| Diaminopyrimidines as P2X.sub.3 and P2X.sub.2/3 antagonists Grant 7,858,632 - Broka , et al. December 28, 2 | 2010-12-28 |
| Diaminopyrimidines as P2X.sub.3 and P2X.sub.2/3 modulators Grant 7,799,796 - Dillon , et al. September 21, 2 | 2010-09-21 |
| Heterocyclic antiviral compounds App 20090208449 - Labadie; Sharada Shenvi ; et al. | 2009-08-20 |
| Inhibitors of P2X.sub.3 Grant 7,491,821 - Brotherton-Pleiss , et al. February 17, 2 | 2009-02-17 |
| Imidazolinylmethyl aralkylsulfonamides Grant 7,407,980 - Dillon , et al. August 5, 2 | 2008-08-05 |
| Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof App 20080146607 - Iyer; Pravin ; et al. | 2008-06-19 |
| Diaminopyrimidines as P2X3 and P2X2/3 modulators App 20070049534 - Dillon; Michael Patrick ; et al. | 2007-03-01 |
| Method for detecting a gram-negative bacterial autoinducer molecule Grant 6,979,696 - Dillon , et al. December 27, 2 | 2005-12-27 |
| Diaminopyrimidines as P2X3 and P2X2/3 antagonists App 20050209260 - Broka, Chris Allen ; et al. | 2005-09-22 |
| Substituted indoles as alpha-1 agonists App 20040224973 - Dillon, Michael Patrick ; et al. | 2004-11-11 |
| Imidazolinyimethyl aralklsulfonamides Grant 6,756,395 - Dillon , et al. June 29, 2 | 2004-06-29 |
| 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives Grant 6,319,920 - Caroon , et al. November 20, 2 | 2001-11-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 